NHS To Offer New Gene Therapy Treatment For Rare Eye Disease

The National Institute for Health and Care Excellence (NICE) approved the use of a new gene therapy treatment that could slow down sight loss.

 

The exciting development could see NHS England patients living with a rare inherited eye disorder access the service as soon as early next year.

 

Charity Retina UK had been actively involved throughout the NICE decision-making process and we spoke with its CEO, Tina Houlihan to find out how the treatment could change lives. 

Ms Houlihan spoke with RNIB Connect Radio’s Simon Pauley.

 

For more information visit: www.retinauk.org.uk